GLS and systemic lupus erythematosus: According to research, administering the GLS1 inhibitor BPTES reduced the excessive differentiation of Th17 cells in naïve CD4+ T cells from SLE patients, which is consistent with the results of GLS1 conditional knockout in the experimental autoimmune encephalomyelitis mouse model (103).